Focus on TAKHZYRO and real-world evidence: Why it matters for your patients with hereditary angioedema (HAE)
Focus on TAKHZYRO and real-world evidence: Why it matters for your patients with hereditary angioedema (HAE)
Welcome and introduction
Milos Jesenak
The impact of HAE on patients
Milos Jesenak
Real-world efficacy, safety, and QoL data in HAE: The TAKHZYRO experience
Aharon Kessel
Real-world management of HAE: The TAKHZYRO experience
Andreas Recke
Panel discussion/Q&A
Milos Jesenak, Aharon Kessel, Andreas Recke
Closing remarks
Milos Jesenak